18 results for author:"Oka N." in Literature citations
Results Customize
› Repeat search in UniProtKB (426)
| NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants. Fu Z.Q., Yan S., Saleh A., Wang W., Ruble J., Oka N., Mohan R., Spoel S.H., Tada Y., Zheng N. et al. Nature 486:228-232(2012) · Mapped (2) |
| Serum level of galectin-3 in human bladder cancer. Sakaki M., Oka N., Nakanishi R., Yamaguchi K., Fukumori T., Kanayama H.O. J. Med. Invest. 55:127-132(2008) · Mapped (9) |
| Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: comparison with serum vascular endothelial growth factor. Tanimoto S., Fukumori T., El-Moula G., Shiirevnyamba A., Kinouchi S., Koizumi T., Nakanishi R., Yamamoto Y., Taue R., Yamaguchi K. et al. J. Med. Invest. 55:106-111(2008) · Mapped (5) |
| Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. Soeda A., Inagaki A., Oka N., Ikegame Y., Aoki H., Yoshimura S., Nakashima S., Kunisada T., Iwama T. J. Biol. Chem. 283:10958-10966(2008) · Mapped (3) |
| Hypoxia-inducible factor 1alpha may be a marker for vasculitic neuropathy. Oka N., Kawasaki T., Mizutani K., Sugiyama H., Akiguchi I. Neuropathology 27:509-515(2007) · Mapped (9) |
| Protein-based peptide-bond formation by aminoacyl-tRNA protein transferase. Watanabe K., Toh Y., Suto K., Shimizu Y., Oka N., Wada T., Tomita K. Nature 449:867-871(2007) · Mapped (1) |
| VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Oka N., Soeda A., Inagaki A., Onodera M., Maruyama H., Hara A., Kunisada T., Mori H., Iwama T. Biochem. Biophys. Res. Commun. 360:553-559(2007) · Mapped (6) |
| Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Hoshino T., Kato S., Oka N., Imaoka H., Kinoshita T., Takei S., Kitasato Y., Kawayama T., Imaizumi T., Yamada K. et al. Am. J. Respir. Crit. Care Med. 176:49-62(2007) · Mapped (7) |
| Src homology 2 domain of overexpressed Lyn kinase is responsible for the acceleration of granulocyte colony-stimulating factor-induced neutrophilic nuclear lobulation. Oka N., Suzuki A., Omura T., Sakai H., Murakami H. Cell Biol. Int. 30:525-532(2006) · Mapped (5) |
| Sequence finishing and gene mapping for Candida albicans chromosome 7 and syntenic analysis against the Saccharomyces cerevisiae genome. Chibana H., Oka N., Nakayama H., Aoyama T., Magee B.B., Magee P.T., Mikami Y. Genetics 170:1525-1537(2005) · UniProtKB (403) |
| On the role of galectin-3 in cancer apoptosis. Nakahara S., Oka N., Raz A. Apoptosis 10:267-275(2005) · Mapped (9) |
| Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. Kikuchi T., Oka N., Koga A., Miyazaki H., Ohmura H., Imaizumi T. J. Cardiovasc. Pharmacol. 45:204-210(2005) · Mapped (1) |
| Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer. Oka N., Yamamoto Y., Takahashi M., Nishitani M., Kanayama H.O., Kagawa S. BJU Int. 95:660-663(2005) · Mapped (2) |
| Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Hayashi T., Arimura T., Ueda K., Shibata H., Hohda S., Takahashi M., Hori H., Koga Y., Oka N., Imaizumi T. et al. Biochem. Biophys. Res. Commun. 313:178-184(2004) · UniProtKB (1) |
| Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Koga A., Oka N., Kikuchi T., Miyazaki H., Kato S., Imaizumi T. Hypertension 42:213-219(2003) · Mapped (1) |
| Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. The study group for hereditary neuropathy in Japan Brain 126:134-151(2003) · UniProtKB (2) |
| Analysis of the gene expression of SPARC and its prognostic value for bladder cancer. Yamanaka M., Kanda K., Li N.C., Fukumori T., Oka N., Kanayama H.O., Kagawa S. J. Urol. 166:2495-2499(2001) · Mapped (1) |
| Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1. Numakura C., Lin C., Oka N., Akiguchi I., Hayasaka K. Ann. Neurol. 47:101-103(2000) · UniProtKB (1) |